Table: Santen Pharm -2021/22 parent results

SANTEN PHARMACEUTICAL

10/05/2022 07:00

May 10 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            190.83          186.11                                
                 (+2.5 pct)      (+1.9 pct)                              
  Operating         21.39           23.61                                
                 (-9.4 pct)      (-31.4 pct)                             
  Recurring         22.53           25.32                                
                 (-11.1 pct)     (-27.4 pct)                             
  Net               17.43           21.75                                
                 (-19.9 pct)     (-20.6 pct)                             
  EPS             43.59 yen       54.44 yen                              
  EPS Diluted     43.53 yen       54.33 yen                              
  Ann Div         32.00 yen       28.00 yen      32.00 yen               
  -Q2 Div         16.00 yen       14.00 yen      16.00 yen               
  -Q4 Div         16.00 yen       14.00 yen      16.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T